Well Referenced

Tag: gynecological cancer

European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis

This 2020 position statement by EMAS and IGCS offers comprehensive guidelines on the management of menopausal symptoms and osteoporosis in women who have undergone treatment for gynecological cancers. It advocates individualized care based on cancer type, treatment history, and hormone receptor status. For women with early-stage, low-grade endometrial cancer, menopausal

Read More »
June 26, 2025 No Comments

Safety of Combined Targeted and Helixor®Viscum album L. Therapy in Breast and Gynecological Cancer Patients, a Real-World Data Study

This observational study examined the safety of combining Helixor® Viscum album L. (a mistletoe extract) with targeted therapy in breast and gynecological cancer patients. The study included 242 patients, with 160 receiving only targeted therapy and 82 receiving a combination of targeted therapy and Helixor® Viscum album L. therapy. Results

Read More »
June 26, 2025 No Comments